Published online Feb 15, 2024. doi: 10.4239/wjd.v15.i2.251
Peer-review started: November 23, 2023
First decision: December 8, 2023
Revised: December 10, 2023
Accepted: January 12, 2024
Article in press: January 12, 2024
Published online: February 15, 2024
Processing time: 73 Days and 0.6 Hours
Prompt detection and precise classification of diabetic retinopathy (DR) in individuals with type 2 diabetes can lessen the likelihood of blindness. Given DR’s intricate causes, relying solely on ophthalmologist examinations may not be enough for effective prevention and treatment. Since endocrinologists frequently encounter diabetic patients initially, they play a crucial role in early DR screening and intervention.
We endeavored to offer fresh perspectives on the screening approaches for DR.
This study investigates the effectiveness of telemedicine enhanced by non-mydriatic fundus photography (NMFP) in evaluating DR and its different stages.
This study retrospectively analyzed 93 diabetic patients, comparing NMFP-assisted telemedicine with fundus fluorescein angiography (FFA) in detecting DR. It aimed to evaluate the agreement between these methods and used receiver operating characteristic (ROC) curves to assess the accuracy of NMFP against the FFA benchmark.
In diagnosing and staging DR, NMFP-assisted telemedicine and FFA showed substantial agreement with kappa coefficients of 0.775 and 0.689, respectively. NMFP’s predictive accuracy for positive FFA outcomes, indicated by a ROC curve area of 0.955 (confidence interval 0.914 to 0.995) and a P-value < 0.001, was high. The model demonstrated 100% specificity, 90.9% sensitivity, and a Youden index of 0.909.
This study introduces NMFP-assisted telemedicine as a practical, accurate method for examining the fundus, especially suitable for endocrinology inpatient care and primary healthcare for diabetic patients. Its use in these settings is crucial for improving the accuracy of diagnosing and treating DR. This approach simplifies patient assessments and significantly improves clinical results in DR management. The new theories proposed by this study include the importance of integrating NMFP-assisted telemedicine into endocrinology and primary healthcare for enhanced DR management. The new method proposed is the application of NMFP-assisted telemedicine itself for fundus examination in diabetic patients.
Future research should focus on expanding the use of NMFP-assisted telemedicine in various healthcare settings for DR management, and conducting larger, long-term studies to evaluate its effectiveness. Additionally, exploring technological improvements and interdisciplinary collaborations can enhance the accuracy and impact of this approach in DR diagnosis and treatment.